Trospium chloride is a muscarinic antagonist used to treat overactive bladder. It has side effects typical of this class of drugs, namely dry mouth, stomach upset, and constipation; these side effects cause problems with people taking their medicine as directed. However it doesn't cause central nervous system side effects like some other muscarinic antagonists.
Chemically it is a quaternary ammonium cation which causes it to stay in periphery rather than crossing the blood–brain barrier. It works by causing the smooth muscle in the bladder to relax.
It was patented in 1966 and approved for medical use in 1974. It was first approved in the US in 2004, and an extended release version was brought to market in 2007. It became generic in the EU in 2009, and the first extended-release generic was approved in the US in 2012. |
Read full article at Wikipedia
|
InChI=1S/C25H30NO3.ClH/c27- 24(25(28,19- 9- 3- 1- 4- 10- 19) 20- 11- 5- 2- 6- 12- 20) 29- 23- 17- 21- 13- 14- 22(18- 23) 26(21) 15- 7- 8- 16- 26;/h1- 6,9- 12,21- 23,28H,7- 8,13- 18H2;1H/q+1;/p- 1/t21- ,22+,23+; |
RVCSYOQWLPPAOA-QKYUOBHYSA-M |
[N+]12([C@]3(C[C@H](OC(C(C4=CC=CC=C4)(C5=CC=CC=C5)O)=O)C[C@@]1(CC3)[H])[H])CCCC2.[Cl-] |
|
muscarinic antagonist
A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
|
|
antispasmodic drug
A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder.
muscarinic antagonist
A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
|
|
View more via ChEBI Ontology
(1S,3R,5R)- 3- [(2- hydroxy- 2,2- diphenylacetyl)oxy]- 8λ5- azaspiro[bicyclo[3.2.1]octane- 8,1'- pyrrolidin]- 8- ylium chloride
|
chlorure de trospium
|
WHO MedNet
|
cloruro de trospio
|
WHO MedNet
|
trospii chloridum
|
WHO MedNet
|
trospium chloride
|
WHO MedNet
|
IP-631
|
ChEBI
|
IP631
|
ChemIDplus
|
Trospium chloride
|
KEGG DRUG
|
trospium Cl
|
ChemIDplus
|
Regurin
|
ChEBI
|
Relaspium
|
ChemIDplus
|
Sanctura
|
ChemIDplus
|
Sanctura XR
|
ChemIDplus
|
Santura
|
ChemIDplus
|
Spasmed
|
ChEBI
|
Spasmex
|
KEGG DRUG
|
Spasmo 3
|
ChemIDplus
|
Spasmo-lyt
|
ChemIDplus
|
Spasmolyt
|
ChEBI
|
Spasmoplex
|
KEGG DRUG
|
Trofame
|
ChEBI
|
Trosec
|
DrugBank
|
Trospikan
|
ChEBI
|
Uraplex
|
ChemIDplus
|
10405-02-4
|
CAS Registry Number
|
ChemIDplus
|
15289745
|
PubMed citation
|
Europe PMC
|
15684176
|
PubMed citation
|
Europe PMC
|
15779697
|
PubMed citation
|
Europe PMC
|
17722614
|
PubMed citation
|
Europe PMC
|
19193592
|
PubMed citation
|
Europe PMC
|
22120415
|
PubMed citation
|
Europe PMC
|
23453648
|
PubMed citation
|
Europe PMC
|
25466967
|
PubMed citation
|
Europe PMC
|
27765726
|
PubMed citation
|
Europe PMC
|
28050642
|
PubMed citation
|
Europe PMC
|
28067745
|
PubMed citation
|
Europe PMC
|
28468509
|
PubMed citation
|
Europe PMC
|
28792105
|
PubMed citation
|
Europe PMC
|
30217174
|
PubMed citation
|
Europe PMC
|
30697533
|
PubMed citation
|
Europe PMC
|
31542894
|
PubMed citation
|
Europe PMC
|
|